<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nguyen M</submitter><funding>Ministry of Health and Welfare</funding><funding>Chonnam National University</funding><funding>National Research Foundation of Korea</funding><pagination>1131-1136</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9290037</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(7)</volume><pubmed_abstract>On the basis of the previously reported polypharmacological profile of truncated d-1'-homologated adenosine derivatives [J. Med. Chem.2020, 63, 16012], the l-nucleoside analogues were synthesized using computer-aided design and evaluated for biological activity. The target molecules were synthesized from d-ribose via the key intramolecular cyclization of the monotosylate and Mitsunobu condensation. The peroxisome proliferator-activated receptor (PPAR) binding activities of l-nucleoside analogue &lt;b>2d&lt;/b> (&lt;i>K&lt;/i> &lt;sub>i&lt;/sub> = 4.3 μM for PPARγ and 1.0 μM for PPARδ) were significantly improved in comparison with those of the d-nucleoside compound &lt;b>1&lt;/b> (11.9 and 2.7 μM, respectively). In addition, the l-nucleosides showed more potent adiponectin-secretion-promoting activity than the d-</pubmed_abstract><journal>ACS medicinal chemistry letters</journal><pubmed_title>Design, Synthesis, and Biological Activity of l-1'-Homologated Adenosine Derivatives.</pubmed_title><pmcid>PMC9290037</pmcid><funding_grant_id>2021-2440</funding_grant_id><funding_grant_id>NRF-2022R1I1A3056585</funding_grant_id><funding_grant_id>NRF-2019R1F1A1063905</funding_grant_id><funding_grant_id>HI20C0079</funding_grant_id><funding_grant_id>NRF-2019R1A2C2085749</funding_grant_id><pubmed_authors>Nguyen Y</pubmed_authors><pubmed_authors>Kim G</pubmed_authors><pubmed_authors>Choi H</pubmed_authors><pubmed_authors>Jeong LS</pubmed_authors><pubmed_authors>Pham L</pubmed_authors><pubmed_authors>Noh M</pubmed_authors><pubmed_authors>Hyun YE</pubmed_authors><pubmed_authors>Kim JA</pubmed_authors><pubmed_authors>Nguyen M</pubmed_authors><pubmed_authors>An S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design, Synthesis, and Biological Activity of l-1'-Homologated Adenosine Derivatives.</name><description>On the basis of the previously reported polypharmacological profile of truncated d-1'-homologated adenosine derivatives [J. Med. Chem.2020, 63, 16012], the l-nucleoside analogues were synthesized using computer-aided design and evaluated for biological activity. The target molecules were synthesized from d-ribose via the key intramolecular cyclization of the monotosylate and Mitsunobu condensation. The peroxisome proliferator-activated receptor (PPAR) binding activities of l-nucleoside analogue &lt;b>2d&lt;/b> (&lt;i>K&lt;/i> &lt;sub>i&lt;/sub> = 4.3 μM for PPARγ and 1.0 μM for PPARδ) were significantly improved in comparison with those of the d-nucleoside compound &lt;b>1&lt;/b> (11.9 and 2.7 μM, respectively). In addition, the l-nucleosides showed more potent adiponectin-secretion-promoting activity than the d-</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2026-05-28T01:23:16.771Z</modification><creation>2025-04-07T10:19:38.201Z</creation></dates><accession>S-EPMC9290037</accession><cross_references><pubmed>35859875</pubmed><doi>10.1021/acsmedchemlett.2c00159</doi></cross_references></HashMap>